NHS FPX 5004 Assessment 4 Self-Assessment of Leadership, Collaboration, and Ethics

• NHS FPX 5004 Assessment 4

Self-Assessment of Leadership, Collaboration, and Ethics

A leader plays a vital role in monitoring organizational performance, ensuring discipline, and identifying areas for improvement. Effective leadership requires guiding the team, enforcing rules, and fostering collaboration for success. Leaders must also offer support and motivation to their team members. This assessment highlights the significance of ethics, collaboration, and leadership in achieving organizational goals while reflecting on personal leadership experiences. Insights from NHS FPX 5004 Assessment 4 emphasize these critical components.

Section 1: Leadership and Collaboration Qualities Relative to Specific Experience

Leadership Experience in Clinical Trials

In 2018, after completing my degree in neurology, I was appointed as a team leader in an organization that conducts clinical trials for epilepsy patients. My responsibilities included motivating and guiding my team members as they developed a medication to treat epilepsy. With 3.5 million individuals affected by epilepsy in the United States, the urgency of this project was apparent (Axon et al., 2019).

As a leader, I ensured my team shared a unified vision and focused on achieving the goal. My role involved supervising clinical trials, facilitating collaboration, and maintaining effective communication to meet organizational objectives. This experience deepened my understanding of leadership and teamwork.

Leadership Approach Implemented

For this project, I employed the HEART approach combined with transformational leadership principles (Singletary, 2020):

• H (High Vision): My focus was aligning stakeholder needs and ensuring effective collaboration for organizational success.
• E (Expert): Leveraging my neurology expertise, I guided team members during clinical trials, showcasing my ability to lead with knowledge and experience.
• A (Adaptive): I demonstrated flexibility, accommodating team members who needed additional guidance, which fostered high morale.
• R (Responsibility): I assigned tasks thoughtfully and ensured all duties were completed on time, reflecting dedication to the organization, stakeholders, and patients.
• T (Team Player): I was approachable and supported team members as equals, promoting open communication and a cohesive work environment.

Using the HEART model enabled me to lead effectively, inspire my team, and meet project goals.

Leadership Style and Outcomes

I adopted a conceptual decision-making style, encouraging creativity and welcoming team input. I was mindful of making decisions that positively impacted everyone involved. By fostering open communication, my team successfully developed the epilepsy medication lamotrigine. This collaborative effort also attracted stakeholders and sponsors, securing funds that expedited project completion (Boaz et al., 2018).

While maintaining a strict yet supportive approach, I ensured team conflicts were resolved promptly. For instance, when disagreements arose among members, I reminded them of their responsibility to prioritize patient safety and care. Clear communication helped unify the team and align everyone with our common goal.

Section 2: Ethical Dilemma and Action

Addressing Ethical Concerns in Clinical Trials

Clinical trials demand dedication and ethical integrity. Participants often have concerns about the processes and outcomes. Leaders must ensure transparency and address these concerns ethically. Two significant ethical dilemmas arose during the trials:

1. Use of Placebos: The use of placebos posed ethical questions about patient safety and treatment efficacy. Strategies were developed to address these concerns and reassure participants (Castelnuovo et al., 2018).
2. Informed Consent: Patients needed detailed information about trial procedures and their implications. I ensured participants were fully informed about potential risks and had the autonomy to decline participation if they felt uncomfortable.

Resolving Ethical Dilemmas

To address these issues, I adhered to autonomy, beneficence, and non-maleficence principles. Patients who expressed concerns were respected and excluded from trials if necessary. I utilized consent forms aligned with WHO standards to ensure transparency and ethical compliance (Solomon et al., 2021).

Additionally, I upheld the code of ethics outlined by the American College of Healthcare Executives. I maintained ethical standards throughout the project by fostering trust and ensuring patient rights were respected.

Tackling Workplace Discrimination

During the trials, workplace discrimination occurred when a senior manager favored an American doctor over a Korean colleague despite the latter’s valid contributions. I escalated the matter to organizational authorities, leading to the manager’s dismissal for violating ethical principles. This action reinforced the importance of fairness and respect in the workplace.

Conclusion

Effective leadership, collaboration, and ethics are fundamental for achieving organizational goals and maintaining a positive work environment. Insights from NHS FPX 5004 Assessment 4 underscore the importance of clear communication, team motivation, and ethical decision-making. Leaders can ensure that their teams work harmoniously toward shared objectives by fostering collaboration, resolving conflicts, and upholding ethical standards. Strong leadership inspires trust, promotes discipline, and drives organizational success.

Read more NHS FPX 5004 Assessment 3 Diversity Project Kickoff Presentation about for complete information about this class.

References

American College of Healthcare Executives. (2021, December 6). ACHE Code of Ethics. Ache.org. https://www.ache.org/about-ache/our-story/our-commitments/ethics/ache-code-of-ethics

Axon, D. R., Taylor, A. M., Vo, D., & Bingham, J. (2019). Initial assessment of an interprofessional team-delivered telehealth program for patients with epilepsy. Epilepsy Research, 158, 106235. https://doi.org/10.1016/j.eplepsyres.2019.106235

Boaz, A., Hanney, S., Borst, R., O’Shea, A., & Kok, M. (2018). How to engage stakeholders in research: design principles to support improvement. Health Research Policy and Systems, 16(1). https://doi.org/10.1186/s12961-018-0337-6

Bunger, A. C., & Lengnick-Hall, R. (2018). Do learning collaboratives strengthen communication? A comparison of organizational team communication networks over time. Health Care Management Review, 43(1), 50–60. https://doi.org/10.1097/hmr.0000000000000120

Castelnuovo, G., Giusti, E. M., Manzoni, G. M., Saviola, D., Gabrielli, S., Lacerenza, M., Pietrabissa, G., Cattivelli, R., Spatola, C. A. M., Rossi, A., Varallo, G., Novelli, M., Villa, V., Luzzati, F., Cottini, A., Lai, C., Volpato, E., Cavalera, C., Pagnini, F., & Tesio, V. (2018). What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation. Frontiers in Neurology, 9. https://doi.org/10.3389/fneur.2018.00310

Clark, L. T., Watkins, L., Piña, I. L., Elmer, M., Akinboboye, O., Gorham, M., Jamerson, B., McCullough, C., Pierre, C., Polis, A. B., Puckrein, G., & Regnante, J. M. (2019). Increasing diversity in clinical trials: Overcoming critical barriers. Current Problems in Cardiology, 44(5), 148–172. https://doi.org/10.1016/j.cpcardiol.2018.11.002

Cornett, J. A., & Kuziemsky, C. (2018). Team-based communication and the healthcare communication space. Journal of Health Organization and Management, 32(6), 825–840. https://doi.org/10.1108/jhom-07-2017-0189

Singletary, J. (2020). Head, heart, and hand. Social Work & Christianity, 47(4), 3–18. https://doi.org/10.34043/swc.v47i3.126

Solomon, E. D., Mozersky, J., Baldwin, K., Wroblewski, M. P., Parsons, M. V., Goodman, M., & DuBois, J. M. (2021). Perceived barriers to assessing understanding and appreciation of informed consent in clinical trials: A mixed-method study. Journal of Clinical and Translational Science, 5(1). https://doi.org/10.1017/cts.2021.807

Stern, G., Horn, H., DeFrancesco, J., Ruiz, J., Linton, J., Marchant, M., & Smith, D. (2020). Roundtable discussion: supporting medical devices during unprecedented challenges. Biomedical Instrumentation & Technology, 54(3), 202–208. https://doi.org/10.2345/0899-8205-54.3.202